You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dose Fractionation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testosterone, Transsexualism, Hematologic Diseases Trial (Testosterone Cypionate 100 MG/ML)

Not yet recruiting
  • Testosterone
  • +2 more
  • Testosterone Cypionate 100 MG/ML
  • (no location specified)
Aug 1, 2022

Endometrial Cancer Trial in Baltimore, Syracuse, Charlottesville (HDR vaginal brachytherapy)

Recruiting
  • Endometrial Cancer
  • HDR vaginal brachytherapy
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Heel Spur Trial in Brno (Standard fractioned dose, Experimental single dose)

Recruiting
  • Heel Spur
  • Standard fractioned dose
  • Experimental single dose
  • Brno, Czechia
    Masaryk Memorial Cancer Institute
Oct 30, 2023

Breast Cancer Trial in Baltimore, Dallas (Dose Fractionation)

Active, not recruiting
  • Breast Cancer
  • Dose Fractionation
  • Baltimore, Maryland
  • +1 more
Sep 7, 2022

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Radiation Field, Dose and Fractionation Related to Mandibular

Recruiting
  • Head and Neck Neoplasms
  • +2 more
  • Radiotherapy
  • Lund, Sweden
    Skane University Hospital
Jun 7, 2022

Prostate Cancer Trial in Toronto (Sterotactic Body Radiotherapy, Conventionally Fractionated Radiation)

Recruiting
  • Prostate Cancer
  • Sterotactic Body Radiotherapy
  • Conventionally Fractionated Radiation
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 3, 2022

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022

Prostate Cancer Trial in New York (117Lu-J591)

Completed
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College-New York Presbyterian Hospital
Mar 16, 2021

Tumor Metastases, Metastases, Tumor Trial in United States (EXTERNAL BEAM RADIATION)

Not yet recruiting
  • Neoplasm Metastases
  • Metastases, Neoplasm
  • EXTERNAL BEAM RADIATION
  • Hamilton, New Jersey
  • +4 more
Nov 16, 2022

Observing Palliative Asymptomatic Centrally Located Advanced

Active, not recruiting
  • Non-small Cell Lung Carcinoma
  • None: Questionnaire Study
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 6, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Dallas (Intensity-modulated Radiation Therapy (IMRT))

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Intensity-modulated Radiation Therapy (IMRT)
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 22, 2021

Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

Recruiting
  • Prostate Cancer
  • +2 more
  • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
  • +7 more
  • Quebec, Canada
    CHUdeQuebec
Apr 7, 2023

Prostate Cancer Trial (Hypofractionated IMRT Radiation treatment)

Active, not recruiting
  • Prostate Cancer
  • Hypofractionated IMRT Radiation treatment
  • (no location specified)
Sep 27, 2022

Prostate Cancer Trial in Toronto (Conventionally Fractionated versus Hypofractionated Boost)

Active, not recruiting
  • Prostate Cancer
  • Conventionally Fractionated versus Hypofractionated Boost
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
Mar 6, 2022

Melanoma Trial in Nice (Protontherapy)

Terminated
  • Melanoma
  • Protontherapy
  • Nice, France
    Centre Antoine Lacassagne
Dec 12, 2022

DIPG Trial in Mumbai (Bevacizumab Injection, Ultra-low-dose RT)

Recruiting
  • DIPG
  • Bevacizumab Injection
  • Ultra-low-dose RT
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Apr 28, 2022

Breast Cancer, Radiotherapy; Complications Trial (Hypofractionation, Conventional Fractionation)

Not yet recruiting
  • Breast Cancer
  • Radiotherapy; Complications
  • Hypofractionation
  • Conventional Fractionation
  • (no location specified)
Feb 23, 2022

Bladder Cancer Trial in Seoul (hypo-IMRT)

Recruiting
  • Bladder Cancer
  • hypo-IMRT
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 6, 2022

HF-SRT vs. HS-WBRT in Treating Brain Oligometastases

Not yet recruiting
  • Brain Oligometastases
  • Hypofractionated Stereotactic Radiotherapy (HF-SRT)
  • Hippocampus-Sparing Whole-Brain Radiotherapy (HS-WBRT) plus memantine
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 28, 2023

Non Small Cell Lung Cancer, Small Cell Lung Cancer, Thymoma Trial in Durham (Esophageal sparing IMRT)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • Esophageal sparing IMRT
  • Durham, North Carolina
    Duke University Medical Center
Mar 31, 2020

NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • New York, New York
    NYU Langone Health
Jan 11, 2023

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Prostate Cancer Trial in New York (177Lu-PSMA-617, 177Lu-J591, 68Ga-PSMA-HBED-CC)

Terminated
Has Results
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College
Jul 29, 2021

Radiation Therapy for Hematologic Malignancies

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Data Capture
  • Electronic Medical Record
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2021